Clinical Toxicology 2013-07-01

How often do false-positive phencyclidine urine screens occur with use of common medications?

Arvind Rengarajan, Michael E Mullins

Index: Clin. Toxicol. (Phila.) 51(6) , 493-6, (2013)

Full Text: HTML

Abstract

Previous reports describe false-positive urine immunoassay screens for phencyclidine (PCP) associated with use of tramadol, dextromethorphan, or diphenhydramine. The likelihood of these false positives is unknown.We sought to find the relative frequency of false-positive PCP screens associated with these medications and to look for any other medications with similar associations.In an IRB-approved study, we retrospectively reviewed charts of all ED encounters with positive urine screens for PCP in our hospital from 2007 through 2011, inclusive. Urine samples were tested for drugs of abuse using the Siemens Syva EMIT II Immunoassay. Our laboratory routinely confirmed all positive screens using GC-MS with results classified as either "confirmed" (true positive) or "failed to confirm" (false positive). We recorded all medications mentioned in the chart as current medications or medications given before the urine sample. We used Fisher's exact test to compare frequencies of tramadol, dextromethorphan, diphenhydramine, and other medications between the two groups.Tramadol, dextromethorphan, alprazolam, clonazepam, and carvedilol were significantly more frequent among the false-positive group, but the latter three were also associated with polysubstance abuse. Diphenhydramine was more frequently recorded among the false-positive group, but this was not statistically significant.False-positive urine screens for PCP are associated with tramadol and dextromethorphan and may also occur with diphenhydramine. Positive PCP screens associated with alprazolam, clonazepam, and carvedilol were also associated with polysubstance abuse.


Related Compounds

Related Articles:

Ontogenetic influence on rat susceptibility to lindane seizure after pretreatment with phencyclidine.

2013-03-01

[Environ. Toxicol. Pharmacol. 35(2) , 161-70, (2013)]

Behavioral phenotypes in schizophrenic animal models with multiple combinations of genetic and environmental factors.

2013-01-01

[J. Pharmacol. Sci. 121(3) , 185-91, (2013)]

Cariprazine, a dopamine D(3)-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse.

2013-03-01

[Psychopharmacology 226(1) , 91-100, (2013)]

mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.

2014-04-01

[J. Pharmacol. Exp. Ther. 349(1) , 155-64, (2014)]

Differential effects of subchronic phencyclidine on anxiety in the light-enhanced startle-, light/dark exploration- and open field tests.

2013-04-15

[Behav. Brain Res. 243 , 61-5, (2013)]

More Articles...